Form 4: Palisade Bio Director Donald Allen Williams Acquires 2,100 Stock Options as Compensation

Director Donald Allen Williams of Palisade Bio, Inc. received 2,100 common stock options as part of his compensation for services as a director.

Summary

• On July 11, 2024, Donald Allen Williams, a director of Palisade Bio, Inc. (PALI), acquired 2,100 common stock options.
• These options were granted as partial compensation for his services as a director, in accordance with the Issuer's non-employee director compensation policy.
• The options were issued from Palisade Bio's 2021 Equity Incentive Plan.
• Each option allows the purchase of one share of common stock at an exercise price of $4.49.
• The options vest fully on the one-year anniversary of the grant date and expire on July 11, 2034.
• Following this transaction, Williams beneficially owns 2,100 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The document reports a standard compensation practice, which is generally viewed favorably as it aligns director interests with shareholders.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service and contribution from the director.

Industry Context

Stock options are a common form of compensation for directors, aligning their interests with the long-term success of the company.

Comparison to Industry Standards

• Director compensation packages vary widely across the biotechnology industry.
• Stock options are a typical component, often vesting over a period of years to incentivize long-term commitment.
• Comparing the size and terms of this option grant to those of directors at comparable companies (e.g., other small-cap biotech firms) would provide a benchmark for assessing its competitiveness.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it incentivizes the director to work towards increasing shareholder value.
• The director benefits from the potential future value of the stock options.

Key Dates

Keywords

Palisade Bio, Director Compensation, Stock Options, Form 4, Equity Incentive Plan, Beneficial Ownership, PALI, Donald Allen Williams